Frontlight ResearchEarly access
Trial site
Hosp. Virgen Del Rocio
- 6running trials
- 3closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Bladder cancer2 trials
- Myelodysplastic syndromes2 trials
- Acute myeloid leukaemia1 trial
- Chronic myeloid leukaemia1 trial
- Head and neck cancer1 trial
- Hodgkin lymphoma1 trial
- Multiple myeloma1 trial
- Psoriasis1 trial
- Psoriatic arthritis1 trial
- Ulcerative colitis1 trial
- Phase
- Phase 35 trials
- Phase 11 trial
- Phase 1/21 trial
- Phase 21 trial
- Status
- Active, not recruiting3 trials
- Recruiting3 trials
- Completed2 trials
- Withdrawn1 trial
- Lead sponsor
- Janssen Research & Development, LLC7 trials
- Janssen Pharmaceutica N.V., Belgium1 trial
- Johnson & Johnson Enterprise Innovation Inc.1 trial
Running trials
Recruiting
Recruiting
Recruiting
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Head and neck cancer1 recruiting
- Multiple myeloma1 recruiting
Closed trials
Recruiting
Withdrawn
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026